US Patent Issued to Vaxinano on March 3 for "Vaccine to protect against mycoplasma hyopneumoniae" (Dutch, French Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,564,629, issued on March 3, was assigned to Vaxinano SAS (Loos, France).

"Vaccine to protect against mycoplasma hyopneumoniae" was invented by Johanna Jacoba Elisabeth Bijlsma (Boxmeer, Netherlands), Maarten Hendrik Witvliet (Boxmeer, Netherlands) and Didier Betbeder (Loos, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "A vaccine comprising nanoparticles in association with a Mycoplasma hyopneumoniae bacterin, wherein the nanoparticles comprise a cationic polysaccharide and an anionic phospholipid."

The patent was filed on April 19, 2021, under Application No. 17/917,987.

*For further information, including images, charts and tables, please vis...